RELATED CONTENT
NEWS
- Do global clinical trials make the $100-200mn Indian NCE a mirage?
- Lupin licenses NeuClone's cell line as it builds biologics interests
- Alembic rejigs domestic thrust and readies for global generics expansion
- US Capitol Capsule: SEC's rulemaking could blunt crowdfunding's zeal
ANALYSIS
Other Informa Analysis
COMMENT
Other Informa Comment
FEATURES
- Merck BioVentures: where biosimilars make a difference
- Interview: Adimab's Gerngross seeks two sweethearts
EVENTS
Today
Le Plaza Hotel, Brussels, Belgium
Today
Diplomat Hotel, Prague, Czech Republic
Today
Business Design Centre, London
JOB OF THE WEEK

Section Head (m/f)
DRA International/CIS Section

Section Head (m/f)
DRA International/CIS Section

